Bristol-Myers profit dives on year-ago gain

The drug maker reports sharply lower earnings, due largely to a massive gain in the year-ago quarter related to the spin-out of its Mead Johnson division.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.